These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34216264)

  • 1. COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?
    Cavallieri F; Fioravanti V; Toschi G; Grisanti S; Napoli M; Moratti C; Pascarella R; Versari A; Fraternali A; Casali M; Paul JJ; Moro E; Bauer P; Zedde M; Valzania F
    J Neurol; 2022 Jan; 269(1):59-61. PubMed ID: 34216264
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Like a thief in the night': the selectivity of degeneration in Parkinson's disease.
    Saper CB
    Brain; 1999 Aug; 122 ( Pt 8)():1401-2. PubMed ID: 10430827
    [No Abstract]   [Full Text] [Related]  

  • 3. Is COVID-19 a Perfect Storm for Parkinson's Disease?
    Brundin P; Nath A; Beckham JD
    Trends Neurosci; 2020 Dec; 43(12):931-933. PubMed ID: 33158605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter.
    Hartmann A; Hunot S; Hirsch EC
    Exp Neurol; 2003 Dec; 184(2):561-4. PubMed ID: 14769349
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring the relationship between novel Coronavirus pneumonia and Parkinson's disease.
    Xi X; Han L
    Medicine (Baltimore); 2022 Nov; 101(46):e31813. PubMed ID: 36401405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?".
    Outeiro TF; Krisko A
    Mov Disord; 2021 Feb; 36(2):278-279. PubMed ID: 33599004
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy.
    Zange L; Noack C; Hahn K; Stenzel W; Lipp A
    Brain; 2015 Aug; 138(Pt 8):2310-21. PubMed ID: 26017579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk and course of COVID-19 in patients with Parkinson's disease].
    Zalyalova ZA; Khasanova DM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):152-156. PubMed ID: 34693704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 in Parkinson's Disease Patients: A Case-Control Study.
    Salari M; Etemadifar M; Zali A; Medghalchi A; Tehrani Fateh S; Aminzade Z; Bagheri Moghaddam S
    Mov Disord; 2021 Apr; 36(4):794-795. PubMed ID: 33733511
    [No Abstract]   [Full Text] [Related]  

  • 10. Parkinson's Disease and COVID-19: Do We Need to Be More Patient?
    Gonzalez-Latapi P; Fearon C; Fasano A; Lang AE
    Mov Disord; 2021 Feb; 36(2):277. PubMed ID: 33599003
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinson's Disease and Post-COVID-19 Syndrome: The Parkinson's Long-COVID Spectrum.
    Leta V; Rodríguez-Violante M; Abundes A; Rukavina K; Teo JT; Falup-Pecurariu C; Irincu L; Rota S; Bhidayasiri R; Storch A; Odin P; Antonini A; Ray Chaudhuri K
    Mov Disord; 2021 Jun; 36(6):1287-1289. PubMed ID: 33890344
    [No Abstract]   [Full Text] [Related]  

  • 12. Neural degeneration in Parkinson's disease.
    Riederer P; Reichmann H; Janetzky B; Sian J; Lesch KP; Lange KW; Double KL; Nagatsu T; Gerlach M
    Adv Neurol; 2001; 86():125-36. PubMed ID: 11553969
    [No Abstract]   [Full Text] [Related]  

  • 13. Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates.
    Collier TJ; Kanaan NM; Kordower JH
    Nat Rev Neurosci; 2011 Jun; 12(6):359-66. PubMed ID: 21587290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First signs of glaucoma injury occur in the brain. What has generally been considered an eye disease is actually related to conditions such as Alzheimer's and Parkinson's diseases.
    Duke Med Health News; 2010 May; 16(5):4-5. PubMed ID: 20518132
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins.
    Anderson G; Maes M
    Mol Neurobiol; 2014 Apr; 49(2):771-83. PubMed ID: 24085563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
    Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
    Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF: a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of Parkinson's disease.
    McCoy MK; Ruhn KA; Blesch A; Tansey MG
    Adv Exp Med Biol; 2011; 691():539-40. PubMed ID: 21153359
    [No Abstract]   [Full Text] [Related]  

  • 18. Copper Increases Brain Oxidative Stress and Enhances the Ability of 6-Hydroxydopamine to Cause Dopaminergic Degeneration in a Rat Model of Parkinson's Disease.
    Cruces-Sande A; Rodríguez-Pérez AI; Herbello-Hermelo P; Bermejo-Barrera P; Méndez-Álvarez E; Labandeira-García JL; Soto-Otero R
    Mol Neurobiol; 2019 Apr; 56(4):2845-2854. PubMed ID: 30066305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 in Parkinson's disease: Report on prevalence and outcome.
    Artusi CA; Romagnolo A; Imbalzano G; Marchet A; Zibetti M; Rizzone MG; Lopiano L
    Parkinsonism Relat Disord; 2020 Nov; 80():7-9. PubMed ID: 32920322
    [No Abstract]   [Full Text] [Related]  

  • 20. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.
    Weintraub D; Dietz N; Duda JE; Wolk DA; Doshi J; Xie SX; Davatzikos C; Clark CM; Siderowf A
    Brain; 2012 Jan; 135(Pt 1):170-80. PubMed ID: 22108576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.